Stock comparison
IDEXX Laboratories
Molina Healthcare
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$44.06B
Sector
Healthcare
MOH
Molina Healthcare
Market cap
$9.59B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | MOH | Winner |
|---|---|---|---|
| Warren Buffett | 75B | 27F | IDXX |
| Benjamin Graham | 80A | 75B | IDXX |
| Philip Fisher | 75B | 29F | IDXX |
| Peter Lynch | 71B | 24F | IDXX |
| Joel Greenblatt | 83C | 16F | IDXX |
| Charlie Munger | 87A | 31F | IDXX |
| Terry Smith | 84A | 25F | IDXX |
Side-by-side metrics
| Metric | IDXX | MOH |
|---|---|---|
| Market cap | $44.06B | $9.59B |
| P/E (TTM) | 39.0x | 50.2x |
| EV/EBIT | 31.6x | 10.6x |
| ROIC (TTM) | 40.66% | 5.27% |
| Gross margin | 62.05% | 9.59% |
| Net margin | 24.63% | 0.42% |
| Revenue CAGR 5y | 7.56% | 13.09% |
| EPS CAGR 5y | 10.79% | -5.92% |
| Debt / Equity | 0.7x | 1.0x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- EPS CAGR 5y10.79%vs -5.92%+155%
- Net margin24.63%vs 0.42%+98%
- ROIC (TTM)40.66%vs 5.27%+87%
- Gross margin62.05%vs 9.59%+85%
MOH leads on
- EV/EBIT10.6xvs 31.6x+66%
- Revenue CAGR 5y13.09%vs 7.56%+42%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.